Stock Market & Financial Investment News

News For CBST From The Last 14 Days Check below for free stories on CBST the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 17, 2013 05:51 EDT CBST Stocks with implied volatility movement; CBST CELG Subscribe for More Information May 16, 2013 07:29 EDT CBST Leerink to host a bus tour Boston Biopharma Bus Tour travels throughout Boston on May 16-17. May 15, 2013 17:46 EDT CBST SAC Capital gives quarterly update on stakes NEW STAKES: Discovery (DISCA), Liberty Global (LBTYA), Liberty Media (LMCA), Norwegian Cruise Line (NCLH), and Cubist (CBST). INCREASED STAKES: Suncor (SU), EQT Corporation (EQT), Amazon.com (AMZN), Visa (V), and GNC Holdings (GNC). DECREASED STAKES: News Corp. (NWSA), Facebook (FB), Sherwin-Williams (SHW), and Avago (AVGO). LIQUIDATED STAKES: Coach (COH), Dover (DOV), and Virgin Media (VMED), . 16:00 EDT CBST Optimer calls active following takeover report Optimer (OPTR) May and June 17 calls are active on 5,600 contracts (500 puts) according to Track Data. Traders are taking positions for large price movement on Cubist (CBST) offered to buy the company for $20 per share, Reuters says. 15:54 EDT CBST Optimer up 12.5%, to $16.03 after Reuters report Cubist offered $20 per share Subscribe for More Information 15:53 EDT CBST Cubist offered to buy Optimer for $20 per share, Reuters says Subscribe for More Information May 13, 2013 16:53 EDT CBST Optimer gets bids from AstraZeneca, Cubist, Astellas, Bloomberg says Optimer (OPTR) has received first round bids from AstraZeneca (AZN), Cubist (CBST), and Astellas, reports Bloomberg, citing people familiar with the matter. Shares of Optimer spiked higher following the report, closing up $1.85, or 14.44%, to $14.66. The report notes the company disclosed almost three months ago it was exploring its strategic options. Reference Link 15:55 EDT CBST Optimer gets first round bids from AstraZeneca, Cubist, Bloomberg says Subscribe for More Information May 7, 2013 08:34 EDT CBST FDA grants fast track desingation for Cubist's late-stage antibiotic candidate Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.